Discovery of novel microRNA mimic repressors of ribosome biogenesis

Carson J Bryant,Mason A McCool,Gabriela T Rosado González,Laura Abriola,Yulia V Surovtseva,Susan J Baserga

DOI: https://doi.org/10.1093/nar/gkad1235

IF: 14.9

2024-01-11

Nucleic Acids Research

Abstract:While microRNAs and other non-coding RNAs are the next frontier of novel regulators of mammalian ribosome biogenesis (RB), a systematic exploration of microRNA-mediated RB regulation has not yet been undertaken. We carried out a high-content screen in MCF10A cells for changes in nucleolar number using a library of 2603 mature human microRNA mimics. Following a secondary screen for nucleolar rRNA biogenesis inhibition, we identified 72 novel microRNA negative regulators of RB after stringent hit calling. Hits included 27 well-conserved microRNAs present in MirGeneDB, and were enriched for mRNA targets encoding proteins with nucleolar localization or functions in cell cycle regulation. Rigorous selection and validation of a subset of 15 microRNA hits unexpectedly revealed that most of them caused dysregulated pre-rRNA processing, elucidating a novel role for microRNAs in RB regulation. Almost all hits impaired global protein synthesis and upregulated CDKN1A (p21) levels, while causing diverse effects on RNA Polymerase 1 (RNAP1) transcription and TP53 protein levels. We provide evidence that the MIR-28 siblings, hsa-miR-28-5p and hsa-miR-708-5p, potently target the ribosomal protein mRNA RPS28 via tandem primate-specific 3′ UTR binding sites, causing a severe pre-18S pre-rRNA processing defect. Our work illuminates novel microRNA attenuators of RB, forging a promising new path for microRNA mimic chemotherapeutics.

biochemistry & molecular biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to systematically explore how microRNAs (miRNAs) regulate mammalian ribosome biogenesis (RB). Specifically, the authors conducted a high - content screening experiment, using a library of 2,603 mature human miRNA mimics, and observed changes in the number of nucleoli in the human breast epithelial cell line MCF10A to identify novel miRNAs that may negatively regulate RB.

Through this screening, the researchers hope to discover new miRNA inhibitors that can affect the rRNA biosynthesis process in the nucleolus, thereby revealing new roles of miRNAs in RB regulation. In addition, they also hope to further understand how these miRNAs affect pre - rRNA transcription and processing, overall protein synthesis, and cell cycle progression, especially mRNA targets related to cell cycle regulation, by validating some of the screened miRNAs.

The key findings of the study include:
- 72 novel miRNA negative regulators that can interfere with RB were identified.
- 27 of these miRNAs are highly conserved and exist in the MirGeneDB database.
- A group of 15 miRNAs was validated, and it was found that most of them led to the dysregulation of pre - rRNA processing, which revealed a new role of miRNAs in RB regulation.
- The MIR - 28 family members hsa - miR - 28 - 5p and hsa - miR - 708 - 5p were particularly emphasized. These two miRNAs strongly inhibit the processing of pre - 18S pre - rRNA by targeting tandem primate - specific binding sites in the 3′ untranslated region (3′ UTR) of the ribosomal protein mRNA RPS28.

Overall, this study not only fills the gap in the understanding of how miRNAs regulate RB, but also provides new possibilities for the development of chemotherapy drugs based on miRNA mimics.